Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
The current price of ARSUF is $26.53 USD — it has decreased by -1.74% in the past 24 hours. Watch Fagron NV stock price performance more closely on the chart.
What is Fagron NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fagron NV stocks are traded under the ticker ARSUF.
What is Fagron NV market cap?▼
Today Fagron NV has the market capitalization of 1.94B
When is the next Fagron NV earnings date?▼
Fagron NV is going to release the next earnings report on July 30, 2026.
What is Fagron NV revenue for the last year?▼
Fagron NV revenue for the last year amounts to 2.8B USD.
What is Fagron NV net income for the last year?▼
ARSUF net income for the last year is 267.29M USD.
Does Fagron NV pay dividends?▼
Yes, ARSUF dividends are paid annual. The last dividend per share was 0.4 USD. As of today, Dividend Yield (FWD)% is 1.49%.
How many employees does Fagron NV have?▼
As of April 17, 2026, the company has 3,828 employees.
In which sector is Fagron NV located?▼
Fagron NV operates in the Health & Wellness sector.